Sugi Predict

Sugi Predict / Compounds / SCHEMBL1246210

SCHEMBL1246210

SCHEMBL1246210

OCCCCCCCCCCCCOCc1ccccc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 2/20 0.54
▸ TDP1 Q9NUW8 1/20 0.54
▸ TSHR P16473 1/20 0.54
▸ UGCG Q16739 5/20 0.50
▸ GBA2 Q9HCG7 5/20 0.50
▸ GBA1 P04062 4/20 0.50
▸ EPHX2 P34913 3/20 0.47
▸ LTA4H P09960 1/20 0.47
▸ KDM4E B2RXH2 1/20 0.46
▸ POLB P06746 1/20 0.46
▸ HRH4 Q9H3N8 1/20 0.45
▸ HRH3 Q9Y5N1 1/20 0.45
▸ ADRB2 P07550 1/20 0.43
▸ ADRB1 P08588 1/20 0.43
▸ ADRB3 P13945 1/20 0.43
▸ LCT P09848 2/20 0.43
▸ SI P14410 2/20 0.43
▸ MGAM O43451 1/20 0.43
▸ TEAD3 Q99594 1/20 0.42
▸ NAAA Q02083 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL518615 1.00 L3MBTL1 (0.54) L3MBTL1TDP1TSHRUGCGGBA2
SCHEMBL8482826 1.00 L3MBTL1 (0.54) L3MBTL1TDP1TSHRUGCGGBA2
SCHEMBL6212152 1.00 L3MBTL1 (0.54) L3MBTL1TDP1TSHRUGCGGBA2
SCHEMBL96809 1.00 L3MBTL1 (0.54) L3MBTL1TDP1TSHRUGCGGBA2
SCHEMBL9684333 1.00 L3MBTL1 (0.54) L3MBTL1TDP1TSHRUGCGGBA2
SCHEMBL25208054 1.00 L3MBTL1 (0.54) L3MBTL1TDP1TSHRUGCGGBA2
SCHEMBL97795 1.00 L3MBTL1 (0.54) L3MBTL1TDP1TSHRUGCGGBA2
SCHEMBL814418 1.00 L3MBTL1 (0.54) L3MBTL1TDP1TSHRUGCGGBA2
SCHEMBL1007794 1.00 L3MBTL1 (0.54) L3MBTL1TDP1TSHRUGCGGBA2
SCHEMBL22906771 0.98 L3MBTL1 (0.53) L3MBTL1TDP1TSHRUGCGGBA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260103480-A1 NUCLEOTIDE PRECURSORS, NUCLEOTIDE ANALOGS AND OLIGOMERIC COMPOUNDS CONTAINING THE SAME SANOFI SA (FR) 2026-04-16 — — US disclosed
US-20250057747-A1 ORGANIC COMPOUNDS AS FRAGRANCE GIVAUDAN SA (CH) 2025-02-20 — — US disclosed
CN-112105625-B Nucleotide precursors, nucleotide analogs and oligomeric compounds containing the same 赛诺菲 2024-12-31 — — CN disclosed
US-20240376137-A1 NUCLEOTIDE PRECURSORS, NUCLEOTIDE ANALOGS AND OLIGOMERIC COMPOUNDS CONTAINING THE SAME SANOFI SA (FR) 2024-11-14 — — US disclosed
EP-4437072-A1 ORGANIC COMPOUNDS AS FRAGRANCE Givaudan SA (CH) 2024-10-02 — — EP disclosed
CN-118369410-A Organic compounds as fragrances 奇华顿股份有限公司 2024-07-19 — — CN disclosed
US-11897911-B2 Nucleotide precursors, nucleotide analogs and oligomeric compounds containing the same SANOFI (FR) 2024-02-13 — — US disclosed
WO-2023089158-A1 ORGANIC COMPOUNDS AS FRAGRANCE GIVAUDAN SA (CH) 2023-05-25 — — WO disclosed
US-20220372063-A1 OLIGONUCLEOTIDES CONTAINING NUCLEOTIDE ANALOGS SANOFI (FR) 2022-11-24 — — US disclosed
EP-4025582-A1 OLIGONUCLEOTIDES CONTAINING NUCLEOTIDE ANALOGS SANOFI (FR) 2022-07-13 — — EP disclosed
CN-114728999-A Oligonucleotides containing nucleotide analogs 赛诺菲 2022-07-08 — — CN disclosed
US-20210115075-A1 NUCLEOTIDE PRECURSORS, NUCLEOTIDE ANALOGS AND OLIGOMERIC COMPOUNDS CONTAINING THE SAME SANOFI (FR) 2021-04-22 — — US disclosed
CN-112105625-A Nucleotide precursors, nucleotide analogs, and oligomeric compounds containing the same 赛诺菲 2020-12-18 — — CN disclosed
WO-2017040702-A1 BIPOLAR TETRAETHER LIPIDS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2017-03-09 — — WO disclosed
US-20110301370-A1 METHOD FOR PREPARING OREGANIC ACID CONSEJO SUPERIOR DE INVESTIGACIONES CIENTÍFICAS (ES) 2011-12-08 — — US disclosed
CN-102066309-A Method for preparing oreganic acid CONSEJO SUPERIOR INVESTIGACION 2011-05-18 — — CN disclosed
EP-2287146-A1 METHOD FOR PREPARING OREGANIC ACID Consejo Superior de Investigaciones Cientificas (ES) 2011-02-23 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11897911-B2 Nucleotide precursors, nucleotide analogs and oligomeric compounds containing the same RNMT, RRM2B, RRM2 L3MBTL1 425/4885TDP1 481/4885TSHR 1805/4885
US-20210115075-A1 NUCLEOTIDE PRECURSORS, NUCLEOTIDE ANALOGS AND OLIGOMERIC COMPOUNDS CONTAINING THE SAME RNMT, RRM2B, RRM2 L3MBTL1 425/4885TDP1 481/4885TSHR 1805/4885
US-20110301370-A1 METHOD FOR PREPARING OREGANIC ACID OSGEP, OSBP, AOX1 L3MBTL1 4761/4885TDP1 3670/4885TSHR 4547/4885
US-20260103480-A1 NUCLEOTIDE PRECURSORS, NUCLEOTIDE ANALOGS AND OLIGOMERIC COMPOUNDS CONTAINING THE SAME NSUN2, NSUN3, SNRPA L3MBTL1 68/4885TDP1 1779/4885TSHR 1010/4885
US-20250057747-A1 ORGANIC COMPOUNDS AS FRAGRANCE OPRK1, MAFK, OPRM1 L3MBTL1 2979/4885TDP1 4278/4885TSHR 4334/4885
US-20240376137-A1 NUCLEOTIDE PRECURSORS, NUCLEOTIDE ANALOGS AND OLIGOMERIC COMPOUNDS CONTAINING THE SAME RNMT, NSUN2, ADAR L3MBTL1 195/4885TDP1 375/4885TSHR 3889/4885
US-20220372063-A1 OLIGONUCLEOTIDES CONTAINING NUCLEOTIDE ANALOGS DCLRE1B, UPF1, IGF2BP1 L3MBTL1 115/4885TDP1 353/4885TSHR 1308/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.